Metformin attenuates vascular pathology by increasing expression of insulin-degrading enzyme in a mixed model of cerebral amyloid angiopathy and type 2 diabetes mellitus

This publication has 33 references indexed in Scilit:

• Cerebral amyloid angiopathy in the elderly
  Annals of Neurology, 2011
• Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes
  Neuropharmacology, 2011
• Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes
  Proceedings of the National Academy of Sciences, 2010
• γ-Secretase Composed of PS1/Pen2/Aph1a Can Cleave Notch and Amyloid Precursor Protein in the Absence of Nicastrin
  Journal of Neuroscience, 2010
• Antidiabetic drug metformin (Glucophage ^R ) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
  Proceedings of the National Academy of Sciences, 2009
• Role of AMP-activated protein kinase in mechanism of metformin action
  Journal of Clinical Investigation, 2001
• Diabetes mellitus and the risk of dementia
  Neurology, 1999
• Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study
  American Journal of Epidemiology, 1997
• Cerebral amyloid angiopathy in dementia and old age.
  Journal of Neurology, Neurosurgery & Psychiatry, 1986
• The incidence of cerebral amyloid angiopathy in Alzheimer's disease
  Neurology, 1975